Mike Moradi

Mike Moradi is a seasoned entrepreneur and leader with extensive experience in the biotechnology and venture capital sectors. Currently a Kauffman Fellow at Kauffman Fellows and Co-Founder & General Partner at Cortado Ventures, Moradi also serves as Co-Founder and CEO of Sensulin, LLC, which focuses on advancing glucose-responsive insulin for diabetes management. Recognized as a Young Global Leader by the World Economic Forum, Moradi is an active member of the Board of Directors and Investment Committee at Grand Founders, promoting economic development through impactful investments. Previous leadership roles include Founder and CEO of EyeCRO, General Partner at Atomic Venture Partners, and Co-Founder at both Unidym, Inc. and NanoSource Technologies. Moradi received education from prestigious institutions, including the University of Oxford and Harvard Kennedy School, culminating in a B.S. in Biochemistry from the University of Oklahoma.